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  The methanol extract from the leaves of Petasites japonicus 
Maxim  (PJ)  was  studied  for  its  (anti-)mutagenic  effect 
with the SOS chromotest and reverse mutation assay. The 
(anti-)carcinogenic effects were evaluated by the cytotoxicity 
on human cancer line cells and by the function and the 
expression of gap junctions in rat liver epithelial cell. PJ 
extracts significantly decreased spontaneous β-galactosidase 
activity and β-galactosidase activity induced by a mutagen, 
ICR, in Salmonella (S.) typhimurium TA 1535/pSK 1002. 
All doses of the extract (0.08-100 mg/plate) decreased the 
reversion frequency induced by benzo (α)pyrene (BaP) in 
S. typhimurium TA 98. It decreased not only the spontaneous 
reversion  frequency but  also that  induced by BaP in  S. 
typhimurium TA 100. PJ extract showed greater cytotoxic 
effects on human stomach, colon and uterus cancer cells 
than  on  other  cancer  cell  types  and  normal  rat  liver 
epithelial cells. Dye transfers though gap junctions were 
significantly  increased  by  PJ  extracts  at  concentrations 
greater than 200 μg/mL and the inhibition of dye transfer 
by  12-O-tetradecanoylphorobol-13-acetate  (TPA)  was 
obstructed  in  all  concentrations  of  PJ.  PJ  significantly 
increased the numbers of gap junction protein connexin 
43,  and  increased  the  protein  expression  decreased  by 
TPA in a dose-dependent manner. Based on these findings, 
PJ is suggested to contain antimutagenic and anticarciono-
genic compounds.
Keywords: anticarcinogenicity, antimutagenicity, gap junction, 
Petasites japonicus Maxim
Introduction 
In the last three decades, many studies have focused on 
the evaluation of the antimutagenic and anticarcinogenic 
activities of vegetables, fruits, and plants in order to develop 
functional food or drugs to prevent cancers [2,4,9]. 
Petasites japonicus Maxim (PJ) is an herb of the tribe 
senecioneae in the family compositae. It is a perennial 
grass, and the lower stalk has been used as food in some 
Asian countries. Petasin and isopetasin, identified in extracts 
of  Petasites hybridus, inhibit the biosynthesis of the 
vasoconstrictive peptide leukotriene, and they are thus 
used in traditional medicine to improve gastrointestinal 
pain [1,3]. Petasiphenol, an extract of PJ, was reported as a 
bio-antimutagen isolated from scapes of PJ [12]. On the 
other hand, petasitenine from young flower stalks of PJ can 
induce neoplasia in the livers of rats, but the mature 
terrestrial part of the cultivated plant does not show car-
cinogenic activity [9,10]. PJ is also known to reduce the 
neurotoxicity induced by kainic acid in mice and to have 
anti-histaminic and anti-allergic effects [12,34,35].
A gene mutation is a permanent DNA sequence change 
and the accumulation of genetic errors results in cancer 
development. The Ames test, which detects frame shift 
mutation or base substitution of DNA, and the SOS 
chromotest (umu test), which detects expression of the 
SOS gene (umuC) caused by DNA damage, have been 
developed for the screening of chemical carcinogenicity 
[21,28].
Cancer is characterized by uncontrolled division and 
malignant growth of cells that present tumor specific 
promoters and mutations of certain types of genes that 
regulate cell growth. Materials that have selective cytotoxic 
effects on cancer cells can be considered as candidate drugs 
for cancer therapy [30].
Gap junctions are intercellular plasma membrane domains 
enriched in channels that allow direct exchange of ions and 
small molecules between adjacent cells. Gap junctions are 
essential for cell growth, proliferation and physiological 
function through communication in normal cells [19]. 
Cancer cells usually have down-regulated levels of gap 
junctions, and the induction of gap junctional intercellular 
communication (GJIC) leads to cell growth inhibition of 
some cancer cells [11]. So, studies on the effects of test 52    Hwan-Goo Kang et al.
compounds on the function of gap junctions can be used as 
prescreening tools for the potential carcinogenicity or 
anticarcinogenicity of compounds [17]. To our knowledge, 
there have been few studies into the effect of PJ on 
anticarcinogenicity involving GJIC.
The present paper studies the (anti-)mutagenic activities 
of the methanol extract from leaves of PJ through the umu 
test and Ames’ test using Salmonella TA 98 and TA 100. 
The anticarcinogenic activity of the extract was also 
investigated by MTT assay for cytotoxicity on cancer line 
cells and gap junctional intercellular communication assay 
in rat liver epithelial cells. 
Materials and Methods
Preparation of methanolic extracts 
PJ leaves were collected during the spring season in the 
Korean Peninsula. They were washed with distilled water 
and then ground using mortar. Ten times methanol in 
volume was poured to the ground PJ leaves and let extract 
some ingredients from PJ for 48 h by shaking at 240 rpm, 
en times in volume and mixed with to extract. Sonication 
was then applied for 30 min. The solution was filtered 
through filter paper (ϕ 185 mm; Advantec, USA) and 
vacuum dried at 40
oC to produce a dark gray colored 
residue. The mean recovery was 2.66% of the initial 
weight. The methanol extract of PJ was dissolved in 50% 
dimethylsulfoxide (DMSO) at concentrations of 0.8, 4, 20, 
100, 250, 500 and 1,000 mg/mL for the (anti-)mutagenic 
assay and 8, 40, 200, 1,000 and 5,000 μg/mL for the (anti-) 
carcinogenicity assay and then sonicated for 1 h to sterilize 
the solution.
Bacterial strains, cell types and chemicals 
The test strains of S. typhimurium TA 98 and TA 100 were 
provided by Dr. Bruce Ames (University of California, 
USA) and S. typhimurium TA 1535/pSK 1002 was supplied 
by Dr. Oda (Perfectual Institute of Public Health, Japan). 
Human gastric cancer cells, colon cancer cells, uterine 
cancer cells, lung cancer cells, and hepatoma cells were 
obtained from the Natural Product Research Institute of 
Seoul National University, Korea. Rat liver epithelial cells 
(WB-F344) were kindly provided by Dr. Trosko JE (Mi-
chigan State University, USA). 6-chloro-9-[3-(2-chloroe-
thylamino)proylamino]-2-methoxyacridine 
dihydrochloride (ICR 191), 12-O-tetradecanoylphorobol- 
13-acetate (TPA), benzo(α)pyrene (BaP) and DMSO were 
obtained from Sigma-Aldrich (USA).
Umu test for (anti-)mutagenic activity
The umu test was performed to detect DNA damage by 
monitoring the expression of the SOS gene (umuC) fused 
with a lacZ  gene (β-galactosidase) according to the 
procedure developed by Oda et al. [28]
Briefly, S. typhimurium TA 1535/pSK 1002 was cultured 
at 37
oC overnight in Luria- Bertani broth medium 
supplemented with ampicillin at 20 μg/mL and diluted 
50-fold with TGA medium (1% bacto tryptone, 0.5% 
NaCl, 0.2% glucose, 20 μg/mL ampicillin). Cultures were 
incubated at 37
oC until the bacterial density reached an 
absorbance of 0.25∼0.3 at 600 nm. The bacterial cultures 
was subdivided into 2.4 mL portions in test tubes, and 100 
μL of test sample, 100 μL of positive control (ICR), and 0.5 
mL of S9 mixture or phosphate buffered saline (PBS) were 
added. The mixtures were incubated at 37
oC for 2 h. The 
expression of umu gene was calculated by β-galactosidase 
activity according to Miller [24]. S9 mixture was prepared 
by the method of Maron and Ames [21] and 1 mL of the 
mixture was mixed with 9 mL of the cofactors.
Reverse mutation assay for (anti-)mutagenic activity
The pre-incubation method of Maron and Ames [21] was 
applied to evaluate the (anti-)mutagenic effect of PJ 
extract. Briefly, 0.1 mL of S. typhimurium TA98 or TA100 
cultured overnight were added to 0.1 mL of sample, 0.1 mL 
of positive control (BaP) or vehicle, and 0.5 mL of S9 
mixture or PBS. The entire mixture was incubated at 37
oC 
in a rotary shaker (125 rpm) for 20 min. After incubation, 
2.0 mL of 0.5M his/bio top agar was added, and mixtures 
were poured onto minimal glucose agar and further 
incubated for 48 h. The toxicity of the test sample was 
determined by examination of the background lawn. The 
S9 mixture was prepared as mentioned above. 
MTT assay for cancer cell viability
After the addition of PJ extract to human gastric cancer 
cells, colon cancer cells, uterine cancer cells, lung cancer 
cells and normal rat liver epithelial cells in 96-well plates 
for 4 days, the cytotoxicity was determined by the MTT 
assay using the method described by Mosmann [27]. 
Briefly, cells were washed once with 37
oC PBS after the 
sample treatment and then 0.1 mL of serum-free medium 
containing 0.1% MTT was added to each well. After 
incubation for 4 h, the cells were centrifuged at 450 × g for 
5 min and the culture medium removed. 0.1 mL of DMSO 
was added to each well to solubilize the formazan formed. 
The plates were shaken gently for 10 min and the 
absorbance was measured at 570 nm. The absorbance of 
treated cells was compared with that of the controls, which 
were exposed only to the vehicle and were considered to 
have a viability value of 100%. The determination of the 
50% inhibition concentration of the extract for each cancer 
cell was carried out by the sigmoidal fitting method (Origin 
6.0; Microcal Software, USA).
Scrape-loading and dye transfer (SLDT) assay
GJIC was determined through the SLDT technique 
according to the method described by El-Fouly et al. [6]. Antimutagenic and anticarcinogenic effect of Petasites japonicus    53
Table 1. Inhibitory effect of Petasites japonicus Maxim (PJ) 
extract on expression of SOS gene (umu C'-'lac Z fusion gene) 











Control 0 140.8 ± 7.8 1.00
PJ 0.08 139.0 ± 4.5 0.99
0.4 131.4 ± 3.9 0.93
2 126.3 ± 2.7* 0.90
10 122.5 ± 2.7
† 0.87
25 111.4 ± 2.0
† 0.79
50 106.6 ± 5.1
† 0.76
100 114.4 ± 3.8
† 0.81
ICR 0.03 364.7 ± 16.9
† 1.00
ICR+ PJ 0.03 + 0.08 372.9 ± 15.9 1.07
0.03 + 0.4 370.9 ± 16.0 1.04
0.03 + 2 372.0 ± 17.4 1.10
0.03 + 10 307.2 ± 10.7
† 0.82
0.03 + 25 216.2 ± 6.1
† 0.47
0.03 + 50 154.3 ± 5.0
† 0.21
0.03 + 100 128.6 ± 2.6
† 0.06
ICR: 2-methoxy-6-chloro-9-(3-(2-chlorethyl) aminopropylamino)
acridine·2HCl. a: Activities of β-galactosidase were presented in 
units and the values are mean ± SE of 6 replicas. b: The ratios are 
defined as the value of the β-galactosidase units of PJ divided by 
those of controls in the case of PJ alone and as the value of 
β-galactosidase unit of ICR+PJ divided by that of ICR alone. 
Significantly different (*p < 0.05 and 
†p < 0.01) from control (in the
case of PJ or ICR only) or ICR (in the case of ICR + PJ), respectively.
WB-F344 cells confluently grown in 35-mm tissue culture 
dish were exposed to the test compound with or without 
TPA for 1, 4, 8, or 24 h. After washing with Ca
2+, Mg
2+-free 
PBS 3 times, 2 mL of 0.05% Lucifer yellow CH dye 
solution  in PBS was added, and then several scrapes were 
made on the monolayer using a surgical blade. The cells 
were incubated for 3 min at room temperature and then 
washed three times with Ca
2+, Mg
2+-free PBS. The cells 
were fixed with 1 mL of 10% buffered formalin solution. 
Dye transferred cells were observed with an inverted 
epifluorescence microscope (×100). 
Immunofluorescent staining for gap junction protein
Immunofluorescent staining for a gap junction protein, 
connexin 43, was carried out according to the method 
described by Matesic [22]. After treatment with test 
sample with or without 0.01 μg/mL of TPA for 8 h, the 
WB-F344 cells were fixed with cold methanol/acetone 
(95 : 5, v/v) for 30 min and then rehydrated with PBS. 
Nonspecific binding sites were blocked with 1% normal 
rabbit serum (Jackson, USA) in PBS for 30 min at room 
temperature. The cells were incubated for 2 h with mouse 
monoclonal anti-connexin 43 (Zymed, USA) diluted 1:100 
in PBS, and then washed with PBS. The cells were treated 
with fluorescence isothiocyanate-conjugated rabbit anti- 
mouse IgG (Jackson, USA) diluted 1 : 100 in PBS for 1 h. 
The numbers of stained gap junction proteins per cell were 
counted (×1,000) using a fluorescence microscope (Nikon, 
Japan). 
Statistics
Statistical analyses of the data were performed with one- 
way ANOVA and Duncan’s multicomparison test using 
PC-STAT Version 1A (StatSoft, USA).
Results
Effect of the extract on β-galactosigase activity in S. 
typhimurium TA 1535/pSK 1002
Methanol extract of PJ produced dose-dependent inhibition 
of spontaneous β-galactosidase activity at concentrations 
of more than 2 mg/0.1 mL in S. typhimurium TA 1535/pSK 
1002. The β-galactosidase activity induced by mutagen 
ICR (0.03 mg/0.1 mL) was also decreased significantly (p 
< 0.01) by simultaneous treatment of the extract at doses 
greater than 10 mg/0.1 mL (Table 1).
Effect on the reversions of S. typhimurium TA 98 
and TA 100
All extract concentrations (0.08∼100 mg/plate) had no 
effect on spontaneous reversions in S. typhimurium TA 98 
and TA 100. Simultaneous treatment of BaP (2 mg/plate) 
with all extract concentrations had no significant effect on 
spontaneous reversions in S. typhimurium TA 100 colonies, 
while extract concentrations of more than 25 mg/plate 
were associated with bacterial toxicity. In S. typhimurium 
TA 98, however, BaP-induced reversions decreased dose- 
dependently with PJ extract concentrations of more than 25 
mg/0.1 mL (p < 0.01) and inhibition ratios were less than 
0.35 (Table 2). 
Inhibition of the viability of cancer cell lines 
The mean 50% inhibitory concentration (IC50) of the 
extract for cellular viability was 550 μg/mL [95% confidence 
interval (CI) 357∼846 μg/mL] for stomach cancer cells, 
503 μg/mL (95% CI 392∼644 μg/mL) for colon cancer 
cells, and 870 μg/mL (95% CI 798∼948 μg/mL) for uterine 
cancer cells, all of which were lower than than the IC50 for 
normal rat liver epithelial cells (2,468 μg/mL; 95% CI 
2,088∼2,918 μg/mL). In case of liver and lung cancer 
cells, the IC50 values were 1,913 μg/mL (95% CI 1,001∼
3,516 μg/mL) and 2,781 μg/mL (95% CI 1,493∼5,108 
μg/mL), respectively - similar to those of normal rat liver 
epithelial cells (Table 3). 54    Hwan-Goo Kang et al.
Table 3. Inhibitory effect of Petasites japonicus Maxim (PJ) 
extract on the viability of normal rat liver epithelial cells and five
human cancer line cells
Cell type IC50 (µg/mL)
Norma rat liver epithelial 2,468 (2,088~2,918)
Human stomach cancer 550 (357~846)
Human colon cancer 503 (392~644)
Human uterine cancer 870 (798~948)
Human liver cancer 1,903 (1,001~3,616)
Human lung cancer 2,781 (1,493~5,180)
IC50s are the 50% growth inhibition concentration obtained by MTT
assay. (  ): 95% confidence interval.
Fig. 1. Gap junctional intercellular communication assayed with 
Lucifer yellow CH dye solution in rat liver epithelial cells. The 
cells were exposed to 0.1% methanol (A), 0.01 μg/mL 12-O- 
tetradecanoylphorobol-13-acetate (TPA) (B) and 0.01 μg/mL 
TPA + 40 μg/mL Petasites japonicus Maxim (C) extract for 1 h. 
The cells were observed under epifluorescence microscope. ×100.
Table 2. Inhibitory effect of Petasites japonicus Maxim (PJ) extract on the reversion frequency induced spontaneously and by 








Control 0 45.3 ± 1.5 1.00 128.5 ± 7.3 1.00
PJ 0.08 50.3 ± 3.3 1.11 128.0 ± 5.8 1.00
0.4 46.4 ± 3.3 1.02 126.5 ± 2.8 0.98
2 53.6 ± 4.5 1.18 136.5 ± 3.6 1.06
10 51.7 ± 5.1 1.14 128.8 ± 4.9 1.00
25 50.3 ± 3.7 1.11 BK
50 49.7 ± 4.7 1.10 BK
100 45.2 ± 2.8 1.00 BK
BaP 2 351.7 ± 25.3* 1.00     634.4. ± 32.1* 1.00
BaP+ PJ 2 + 0.08 358.7 ± 23.7 1.01     565.3 ± 9.1 0.86
2 + 0.4 330.4 ± 23.8 0.93     572.3 ± 28.5 0.88
2 + 2 332.0 ± 19.8 0.91     652.6 ± 20.9 1.02
2 + 10 310.4 ± 26.9 0.84     678.3 ± 15.8 1.09
2 + 25 157.1 ± 10.4* 0.35 BK
2 + 50 92.4 ± 6.5* 0.14 BK
2 + 100 53.0 ± 3.5* 0.03 BK
a: Units of doses for PJ and BaP are mg/plate and µg/plate, respectively. b: Revertants are the number of revertants/plate and the values of mean 
± SE of 9 replicas. c: The ratios are defined as the value of the revertant of PJ divided by that of control in the case of PJ alone and as the 
revertants of BaP + PJ divided by those of BaP alone. BK: Revertants could not be counted because of bacterial killing effect. Significantly
different (*p < 0.01) from control (in the case of BaP) or BaP (in the case of BaP + PJ).
Effect of the extract on GJIC
GJIC was assessed by dye transfer through gap junctions 
after treatment with PJ extract. After treatment with the 
extract at concentrations of more than 200 μg/mL for 1 h, 
transfer of dye through the gap junction increased signifi-
cantly (p < 0.01), but was not significantly different from 
that of the control at all treatment concentrations after 1 h 
of treatment. The simultaneous treatment of extract with 
TPA (0.01 μg/mL) effectively prevented the inhibition of 
dye transfer by TAP 1 h after treatment at all concentrations 
(Fig. 1, Table 4).
Effect  of  the  extract  on  the  expression  of  gap 
junction protein
The number of gap junction proteins (connexin 43) 
expressed was significantly (p  ＜  0.01) increased by Antimutagenic and anticarcinogenic effect of Petasites japonicus    55
Table 4. Effect of Petasites japonicus Maxim (PJ) extract on gap junctional intercellular communication in WB-F344 rat liver epithelial
cells treated with/without TPA
Treatment Dose (µg/mL)
No. of dye-transferred cellsa
148 2 4  h
Control 0 169.9 ± 9.0 189.9 ± 15.1 188.2 ± 8.3     226.6 ± 19.2
PJ 8 173.2 ± 4.8 197.4 ± 17.3 202.7 ± 8.6     223.0 ± 14.2
40 187.3 ± 9.5 198.9 ± 15.0 208.3 ± 6.5 229.6 ± 20.8
200 217.9 ± 14.4
† 206.6 ± 7.0 192.4 ± 9.7 263.3 ± 24.7
1,000 234.4 ± 10.0
† 230.5 ± 19.2
† 242.4 ± 15.2
† 258.4 ± 19.7
5,000 261.2 ± 12.7
† 246.5 ± 12.7
† 226.7 ± 11.2
† 230.3 ± 23.7
TPA 0.01 28.5 ± 2.6
† 27.2 ± 1.7
† 31.3 ± 3.0
†  54.2 ± 6.0
†
TPA+ PJ 0.01 + 8 40.0 ± 3.1* 48.2 ± 4.5
† 88.4 ± 8.2
†  125.3 ± 10.4
†
0.01 + 40 43.4 ± 3.7
† 58.8 ± 6.7
† 108.3 ± 5.8
†  152.1 ± 14.8
†
0.01 + 200 47.4 ± 3.5
† 58.6 ± 3.9
† 145.0 ± 15.5
†  214.8 ± 19.2
†
0.01 + 1,000 58.9 ± 3.9
† 64.4 ± 3.3
† 144.4 ± 18.9
† 189.9 ± 9.2
†
0.01 + 5,000 78.6 ± 6.2
† 68.8 ± 5.0
† 160.4 ± 10.0
†  174.2 ± 14.8
†
TPA: 12-O-tetradecanoylphorbol-13-acetate. a: The values presented are the mean ± SE of 12 (1 h) or 9 (4, 8 and 24 h) replicas. Significantly
different (*p ＜ 0.05 or 
†p ＜ 0.01) from control (in the case of PJ and TPA) or TPA (in the case of TPA + PJ). Dye-transferred cells are 
determined under epifluorescence microscope. ×100. 
Table 5. Effect of Petasites japonicus Maxim (PJ) extract on the
expression of gap junction protein in WB-F344 rat liver epi-










Control 0 11.3 ± 0.7 1.00
PJ 8 12.4 ± 0.2 1.10
40 12.5 ± 0.3 1.11
200 13.6 ± 0.7 1.20
1,000  16.0 ± 0.8
† 1.42
5,000  25.9 ± 1.8
† 2.29
TPA 0.01    3.3 ± 0.1
† 0.29
TPA+ PJ 0.01 + 8     5.5 ± 0.3* 0.49
0.01 + 40     6.9 ± 0.3* 0.61
0.01 + 200       7.7 ± 0.9** 0.68
0.01 + 1,000       9.6 ± 0.5** 0.85
0.01 + 5,000  12.7 ± 0.9
† 1.12
a: The values presented are the mean ± SE of 6 replicas. b: The ratio
is defined as the value of the gap junction numbers per cell of PJ, 
TPA and TPA+PJ divided by those of control. Significantly different
(*p < 0.05 or 
†p < 0.01) from control (in the case of PJ and TPA)
or TPA (in the case of TPA + PJ), respectively.
Fig. 2. Gap junction proteins in rat liver epithelial cells. The cells
were exposed to 0.1% methanol (A), 0.01 μg/mL TPA (B) and 
0.01 μg/mL TPA + 40 μg/mL Petasites japonicus Maxim (C) 
extract for 1 h. The cells were observed under epifluorescence 
microscope. ×1,000.
treatment with extracts at concentrations of more than 
1,000 μg/mL. Inhibition of gap junction expression by 
treatment with extract decreased dose-dependently in the 
presence of TPA (0.01 μg/mL) (Fig. 2, Table 5).
Discussion
It is well known that plants suitable for human diet such as 
garlic, broccoli, hot chili peppers and soybean contain a 
variety of natural antimutagenic and anticarcnogenic 
compounds [31,33]. Controversial results have been reported 
regarding the antimutagenic effect of PJ [9,10,12]. In this 
experiment, PJ methanol extract did not show mutagenic 
activity. Conversely, it showed antimutagenic activity by 
preventing spontaneous DNA damage or DNA damage 
induced by the mutagen ICR in S. typhimurium TA 56    Hwan-Goo Kang et al.
1535/pSK1002. Antimutagens can be classified as “desmu-
tagens” which can inactivate mutagens by directly binding 
them before gene damage occurs, and “bioantimutagens” which 
can affect the recovery or replication of damaged genes 
[18]. Thus our data show that PJ extract could have both 
bioantimutagenic and desmutagenic activity in S. typhimurium 
TA 1535/pSK 1002. In the present study, the extract 
influenced neither spontaneous reversions nor mutagen- 
induced reversions in S. typhimurium TA 100, but it 
decreased BaP-induced reversions whilst having no effect 
on spontaneous reversions in S. typhimurium TA 98. 
Antimutagens generally exhibit their activities by either 
correction of the error-prone SOS response or enhancement 
of an error-free recombinational repair system [16]. We 
suggest that the different results of the two test methods 
come from the fact that different targets are detected by 
each test; the umu test detects activation of the SOS repair 
system using β-galactosidase activity, whereas S. typhimurium 
reversion tests measure the final revertants involved in 
various type of gene mutations, such as base pair substitution 
or frame shift [13,16,28,29]. The difference between S 
.typhimurium TA 98 and TA 100 is that S. typhimurium TA 
98 detects the reversions caused by frame shift mutation, 
while S. typhimurium TA 100 detects reversions originating 
from base pair substitution [21]. These data suggest that PJ 
extract may inhibit the mutagenesis aroused by frame shift 
mutation rather than base pair substitution as it inhibits 
mutagenic activity in S. typhimurium TA 98 but not in S. 
typhimurium TA 100. Furthermore, PJ extract has desmutagenic 
effects, as apposed to bioantimutagenic effects, as it inhibits 
only BaP-induced frame shift mutation whilst having no 
effect on spontaneous reversion. Considering the results of 
the two batteries of mutagenicity tests, PJ extract appears 
to act as a bioantimutagen and desmutagen in the activation 
of the SOS DNA repair system and as a desmutagen in the 
prevention of BaP-induced frame-shift mutation.
The present results show that IC50 for human gastric 
cancer cells, uterine cancer cells, and colon cancer cells is 
lower than that for human liver cancer cells, lung cancer 
cells and rat normal liver epithelial cells. These data 
suggest that the effect of PJ extract can vary according to 
the tissue origin of cancer; there might be a somewhat 
specific relationship between PJ extract and cancer inhibition. 
There have been several controversial results reported 
about the anticarcinogenic effect of PJ depending on the 
growth stage and site of sampling. Petasiphenol, a phenolic 
compound from PJ was reported to be a potent antiangiogenic 
agent [23]. Petasiphenone, a phenol isolated from Climicuifuga 
racemosa also demonstrated inhibitory effects on the 
proliferation of a human prostate cancer line cell [14]. 
However, petasitenine, a pyrrolizidine alkaloid from the 
young flower stalk of PJ was associated with liver cell 
adenoma and hemangioendothelial sarcoma in rats [9,10]. 
Liver sarcoma induced by the flower stalk of PJ in the rat 
was enhanced by simultaneous treatment with carbon 
tetrachloride [26]. Activation of apoptosis pathways is 
understood as a key mechanism by which cytotoxic 
compounds kill tumor cells and blockage of the apoptosis- 
inducing pathway could be an important mechanism for 
resistance to chemotherapy [20]. In this study, PJ extract 
exerted apparent cytotoxic effect on human stomach 
cancer cells and colon cancer cells. Change of apoptosis by 
PJ extract in those cancer cell lines needs to be investigated 
to demonstrate the anti-cancer effect.
The inhibition of GJIC in cells is suggested to be related 
to the carcinogenesis of non-genotoxic chemicals as well 
as to the induction of developmental effects [15,32]. Cancer 
cells are devoid of gap junctions, so that contact inhibition 
does not occur in cancer cells, and growth control is more 
difficult than in normal cells [7,8]. GJIC showed an inverse 
relationship with cell proliferation in a rat hepatoma cell 
line [5]. In this experiment, the methanol extract alone 
increased the transfer of dye and it also obstructed the 
inhibition of dye transfer by TPA in normal rat liver 
epithelial cells. The extract alone increased the number of 
gap junction proteins, and it also increased TPA-induced 
gap junction protein expression. These results show that PJ 
may have some active components which stimulate GJIC 
between cells in normal cells. The tumorigenic or antitu-
morigenic effect of PJ depends on whether the major 
component is petasiphenol or petasitenine [9,10,12]. This 
experiment supports the leaves of PJ containing petasiphenol 
because we collected leaves of mature PJ in late spring in 
the Korean peninsula. We speculate that this component 
may contribute to the anticarcinogenic activities of PJ. 
Petasiphenol inhibits DNA polymerase lambda activity, 
which is specifically expressed in developmentally regulated 
cells such as spermatocytes in the testis and directly binds 
to proliferating cell nuclear antigens [25]. Therefore, we 
speculate that the anticarcinogenic effect may be related to 
the inhibition of DNA polymerase lambda activity. However, 
there are to our knowledge no studies on the effect of 
petasiphenol on gap junctions. Further study is required to 
clarify whether the mechanism of the anticarcinogenicity 
of PJ involves the function of DNA polymerase lambda in 
gap junction induction and to elucidate the relationship 
with petasiphenol.
In conclusion, methanol extract from leaves of PJ appears 
to contain bioactive compounds which have antimutagenic 
and anticarcinogenic activities in vitro.
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